Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial
This study has been completed.
Study NCT00464971   Information provided by Novo Nordisk
First Received: April 23, 2007   Last Updated: December 4, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Atrophic Vaginitis
Additional conditions recognized in this trial
Atrophy
Vaginitis
More general conditions related to this trial
Genital Diseases, Female
Pathological Conditions, Anatomical
Vaginal Diseases
Interventions listed in this trial
17-Beta Estradiol, 25 micrograms
Additional drug interventions recognized in this trial
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Polyestradiol phosphate
More general drug interventions related to this trial
Contraceptive Agents
Contraceptive Agents, Female
Estrogens
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Novo Nordisk


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services